sofosbuvir/velpatasvir / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sofosbuvir/velpatasvir / Generic mfg.
IRCT20130812014333N1: Comparative assessment of the efficacy and safety of add ontreatment with “Sofosbuvir plus Velpatasvir” to “standard of care therapeutic regimen” in patients with COVID-19

Recruiting
3
80
Kermanshah
sofosbuvir/velpatasvir - Generic mfg.
Gilead, Generic mfg., Kermanshah University of Medical Sciences
COVID-19
 
 
NCT03891550: Micro-elimination of Hepatitis C Virus Infection in Uremics

Active, not recruiting
3
135
RoW
Epclusa
Kaohsiung Medical University Chung-Ho Memorial Hospital
Hepatitis C
04/24
04/24

Download Options